Quick Answer
Medicus Pharma Ltd. reported Operating Income Loss of -$34.36 million for the year ending 2025.
- Medicus Pharma Ltd. showed a decrease of -207.3% in Operating Income Loss from 2024 to 2025.
- This data is from Medicus Pharma Ltd.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: -$1.71 million | Q2 2024: -$3.55 million | Q3 2024: -$2.33 million | Q1 2025: -$5.13 million | Q2 2025: -$6.02 million | Q3 2025: -$15.00.
- Over the full 3 years of available data (2023 to 2025), Medicus Pharma Ltd.'s Operating Income Loss has declined by 626.4%.
- Historical annual values: Fiscal year 2025: -$34.36 million | Fiscal year 2024: -$11.18 million | Fiscal year 2023: -$4.73 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: